WHO Advocates For More Research For Long COVID Patients
The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously.
At least 17 million...
First Patient Has Been Enrolled In The Sevuparin Experiment
The treatment for paediatric patients with severe malaria is being evaluated through research.
The first patient has been enrolled in the SEVUSMART study, according to...
NHS To Offer Variant-Busting Booster Before The Winters
The NHS has now laid out plans for the next stage of the COVID-19 vaccination effort, the biggest and most rapid vaccine drive in...
Evidence Shows Alzheimer Benefits From Genuv Cancer Drug
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective...
HIV And COVID-19 Vaccines Could Benefit From Nasal Release
A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through...
Three Viruses That Pharma Sector Needs To Gear Up Against
More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak...
Pharmacopoeias To Promote Vaccine Development And Supply
The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...